StockNews.AI
EBS
StockNews.AI
182 days

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

1. Emergent BioSolutions will host a Q4 2024 earnings call on March 3, 2025. 2. The company will present at the J.P. Morgan Leveraged Finance Conference on February 24. 3. Emergent focuses on public health solutions and aims to enhance 1 billion lives by 2030.

Earnings
-20.32%Current Return
VS
+0.43%S&P 500
$9.7202/18 09:00 AM EDTEvent Start
$7.74502/19 03:28 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

Earnings calls may indicate strong performance, positively influencing investor confidence. Previous earnings calls often lead to price surges if results exceed expectations.

How important is it?

The earnings call and conference attendance suggest strong communication with investors, which is critical for stock performance. Active engagement in such events typically correlates with positive market sentiment.

Why Short Term?

The earnings call is imminent, likely driving short-term investor interest. Past earnings announcements usually have immediate impacts on stock prices.

Related Companies

EBS
Separately, Company leaders will attend and present at J.P. Morgan’s 2025 Leveraged Finance Conference on February 24, 2025 February 18, 2025 08:55 ET  | Source: Emergent BioSolutions GAITHERSBURG, Md., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, March 3, 2025, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year 2024. Participants can access the conference call live via webcast, and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call can be accessed from the Investors page of Emergent’s website. Additional Investor Event – Webcast InformationEmergent will also provide a brief presentation and remarks during J.P. Morgan’s 2025 Leveraged Finance Conference. Participants may access the presentation via webcast at 11:00 am eastern time on Monday, February 24, 2025. About Emergent BioSolutionsAt Emergent, our mission is to protect and enhance life. For over 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify. Investor Contact:Richard S. LindahlExecutive Vice President, CFOlindahlr@ebsi.com   Media Contact:Assal HellmerVice President, Communicationsmediarelations@ebsi.com

Related News